Stock market journalist
Daily Stock Markets News

First Republic, JPMorgan, Iveric Bio, Carvana, GM, and More Stock Market Movers


Shares of

First Republic Bank

(ticker: FRC) were falling 45.9% in premarket trading to $1.90.

JPMorgan Chase

 (JPM) was up 3.6%.

PNC Financial

(PNC), which also was reported to be bidding on the assets of First Republic, fell 1.7%.

Other regional lenders traded mixed.

PacWest Bancorp

(PACW) was down 1.8%,

Western Alliance

rose 0.1% (WAL),

KeyCorp

(KEY) gained 0.1%, and

Zions Bancorp

(ZION) was rising slightly.

Iveric Bio

(ISEE) was rising 18.1% to $38.84 after Japan’s Astellas Pharma agreed to buy the biopharmaceutical company for about $5.9 billion. Astellas will be paying $40 a share for

Iveric Bio
.

Advertisement – Scroll to Continue


Carvana

(CVNA) gained 6.9% following a report from Bloomberg that said creditors holding about 90% of the used-car company’s bonds have proposed a debt-for-equity swap.

XPeng

(XPEV),

Li Auto

(LI), and

NIO

(

NIO

) issued their reports for April deliveries on Monday. U.S.-listed shares of the Chinese electric-vehicle makers were rising in premarket trading, with

XPeng

climbing 1.9%,

Li Auto

gaining 3.6%, and NIO up 0.9%.

General Motors (GM) gained 2.7% after the car maker was upgraded to Overweight from Equal Weight at

Morgan Stanley
.

Allbirds

Advertisement – Scroll to Continue


(BIRD) climbed 3.2% after the shoe brand was upgraded to Outperform from Market Perform by analysts at Telsey Advisory.

Global Payments

(GPN) stock slipped 0.3% after the payments software company beat on first-quarter earnings and raised its fiscal-year guidance. The company also said in a filing that Cameron Bready, current president and chief operating officer, will succeed Jeffrey Sloan as chief executive, effective June 1.

Write to Joe Woelfel at joseph.woelfel@barrons.com





Read More: First Republic, JPMorgan, Iveric Bio, Carvana, GM, and More Stock Market Movers

Subscribe
Notify of
guest
0 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments

Get more stuff like this
in your inbox

Subscribe to our mailing list and get interesting stuff and updates to your email inbox.

Thank you for subscribing.

Something went wrong.